Choosing HeartMate II
Thousands of patients worldwide have reclaimed their lives with HeartMate II,
the most widely used and extensively studied
LVAD in the world. They chose HeartMate II
because of its proven technology, outstanding clinical track record, and Thoratec
Corporation’s 35-year commitment to saving the lives of people with advanced heart failure.
HeartMate II is the only device of its kind FDA approved for both and, sometimes called long-term support.
Destination Therapy is an option for people who are ineligible for a heart transplant.
HeartMate II can help advanced heart failure patients live a longer,
“With heart failure, it was not a matter of if I would get worse, it was a
matter of when, and when it did, my doctors pointed me in the right direction to
the HeartMate II.”
John HeartMate II recipient
Getting an LVAD comes with some risks. For potential complications and adverse events,
For indications for use, contraindications,
warnings, and adverse events view our HeartMate II safety information. Individual experiences, symptoms, situations, and circumstances
may vary. Please consult your physician or qualified healthcare provider regarding
your condition and appropriate medical treatment.